4 | SEC Filings Hub

Filing metadata

Accession number: 0001366244-26-000002
Form type: Form 4
Filer: KalVista Pharmaceuticals, Inc.
CIK: CIK 1348911
Filed: Feb 13, 2026
Reporting period: Feb 11, 2026
Description: Insider transaction

Documents

0001366244-26-000002-index.htm

Complete submission

0001366244-26-000002.txt

directory listing

Filed by

KalVista Pharmaceuticals, Inc.